Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 6, 2007, Pages 1242-1247

  Soygur, Haldun ^a   Palaoglu, Ozden ^b   Akarsu, Eyüp Sabri ^b   Cankurtaran, Eylem Sahin ^a   Ozalp, Elvan ^a   Turhan, Levent ^a   Ayhan, Ismail Hakki ^b  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Cortisol; Dexamethasone suppression test; Interleukin 6; Major depressive disorder

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HAMILTON ANXIETY SCALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-6; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PSYCHIATRIC STATUS RATING SCALES; STATISTICS, NONPARAMETRIC;

EID: 34447561695     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.05.001     Document Type: Article

References (43)

1. Akdemir A., Örsel S.B., Daǧ İ., and Türkçapar M.H. The reliability and validity of Hamilton Rating Scale for Depression. Psychiatry Psychol Psychopharmacol J 4 4 (1996) 251-259 [in Turkish]
2. American Psychiatric Association (APA). Task force report on laboratory tests in psychiatry: the dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry 144 (1987) 1253-1262
3. American Psychiatric Association (APA). (1994). Diagnostic and statistical manual of mental disorders-DSM-IV). Translator: E. Köroǧlu. Ankara. Doctors Publishing Association, 139-145 (in Turkish).
4. Anisman H., Merali Z., Poulter M.O., and Hayley S. Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Des 11 (2005) 963-972
5. Arana G.W., and Baldessarini R.J. Clinical use of the dexamethasone suppression test. In: Meltzer H.Y. (Ed). Psychopharmacology, the third generation of progress (1987), Raven Press, New York 609-615
6. Berk M., Wadee A.A., Kuscke R.H., and O'Neil-Kerr A. Acute phase proteins in major depression. J Psychosom Med 43 5 (1997) 529-534
7. Brambilla F., and Maggioni M. Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand 97 4 (1998) 309-313
8. Carpenter L.L., Heninger G.R., Malison R.T., Tyrka A.R., and Price L.H. Cerebrospinal fluid interleukin (IL)-6 in unipolar depression. J Affect Disord 79 (2004) 285-289
9. Carroll B.J. The dexamethasone suppression test for melancholia. Br J Psychiatry 140 (1982) 292-304
10. Cohen-Cole S.A., Brown F., and McDaniel J.S. Diagnostic assessment of depression in the medically ill patients. In: Stoudemire A., and Gogel (Eds). Psychiatric care of the medical patient (1993), Oxford University Press, New York 53-70
11. De Beaurepaire R. Questions raised by the cytokine hypothesis of depression. Brain Behav Immun 16 5 (2002) 610-617
12. Derogatis L.R., Morrow G.R., and Fetting J. The prevalence of psychiatric disorders among cancer patients. JAMA 249 (1983) 751-757
13. Evans D.L., McCartney C.F., Nemeroff C.B., Raft D., and Quade D. Depression in women treated for gynaecological cancer: clinical and neuroendocrine assessment. Am J Psychiatry 143 (1986) 447-452
14. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders (1997)
15. Frommberger U.H., Bauer J., Haselbauer P., Fraylin A., and Rieman D. IL-6 plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 247 (1997) 228-233
16. Grandi S., Fava G.A., and Cunsolo A. Major depression associated with mastectomy. Med Sci Res 15 (1987) 283-284
17. Hamilton M.A. Rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
18. James L., and Levenson M.D. Oncology. In: Massie M.J., and Grenberg D.B. (Eds). Textbook of psychosomatic medicine. 1st (2005), American Psychiatry Publishing 518
19. Jehn C.F., Kuehnhardt D., Bartholomae A., Pfeiffer S., Krebs M., Regierer A.C., et al. Biomarkers of depression in cancer patients. Cancer 107 (2006) 2723-2729
20. Joffe R.T., Rubinow D.R., Denidoff K.D., Maher M., and Sindelar W.F. Depression and carcinoma of the pancreas. Gen Hosp Psych 8 (1986) 241-245
21. Kubera M., Kenis G., Bosmans E., Zieba A., Nowak G., and Maes M. Plasma levels of IL-6, IL-10, IL-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol J Pharmacol 52 (2000) 237-241
22. Leonard B.E. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol. Biol Psychiatry (England) 25 4 (2001) 767-780
23. Leu S.J., Shiah I.S., Yatham L.N., Cheu Y.M., and Lam R.W. Immune-inflammatory markers in patients with seasonal affective disorders. J Affect Disord 63 (2001) 27-34
24. Maes M., Scharpe S., and Meltzer H.Y. Relation between interleukin activity, acute phase proteins and function of hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 49 (1993) 11-27
25. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuro-Psychopharmacol Biol Psychiatry 19 (1995) 11-38
26. Maes M., Bosmans E., Dejongh R., and Kenis G. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9 (1997) 853-858
27. McDaniel J.S., Musselman D.L., Porter M.R., Reed D.A., and Nemeroff C.B. Depression in patients with cancer. Diagnosis, biology and treatment. Arch Gen Psychiatry 52 (1995) 89-99
28. Morihisa J.M., Rosse R.B., and Cross C.D. Laboratory and other diagnostic tests in psychiatry. In: Hales R.E., Yudofsky J.A., and Talbott (Eds). Textbook of psychiatry (1999), American Psychiatric Press, Washington D.C. 298-299
29. Motivala S.J., Sarfatti A., Olmos L., and Irwin M.R. Inflammatory markers and sleep disturbance in major depression. Psychosom Med 67 (2005) 187-194
30. Musselman D.L., Miller A.H., Porter M.R., Manatunga A., Gao F., Penna S., et al. Higher than plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 158 (2001) 1252-1257
31. Newport N.J., and Nemeroff C.B. Assessment and treatment of depression in the cancer patients. J Psychosom Res 45 (1998) 215-237
32. Osuch E.A., Cora-Locatelli G., Frye M.A., Huggins T., Kimbrell T.A., Ketter T.A., et al. Post RM. Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men. Acta Psychiatr Scand 104 5 (Nov 2001) 397-401
33. Özkürkçügil A. Structured clinical interview for DSM-IV (SCID): Turkish translation and reliability study. J Drug Assess 12 4 (1999) 233-236 [in Turkish]
34. Pomara N., and Gershon S. Treatment-resistant depression in an elderly patient with pancreatic carcinoma: case-report. J Clin Psychiatry 45 10 (1984) 439-440
35. Pompe G.V., Antoni M.H., and Heijnen C.J. Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology 21 (1996) 361-374
36. Raison C.L., and Miller A.H. Depression and cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 54 (2003) 283-294
37. Sluzewska A., Rybakowski J.K., Laciak M., Mackiewicz A., and Sobieska M. IL-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 762 1 (1995) 474-476
38. Song C., and Leonard B.E. Stress, the immune system and depression. Fundamentals of psychoneuroimmunology (2000) 75-93
39. Song C., Lin A., Banaccorse S., Heide C., and Verkerk R. The inflammatory response system and availability of plasma tryptophan in patient with primary sleep disorders and depression. J Affect Disord 49 (1998) 211-219
40. Suares E.C. Joint effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration. Psychosom Med 65 (2003) 523-527
41. Vollmer-Conna U., Fazou C., Cameron B., Li H., Brennan L.L., Luck L., et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 34 (2004) 1289-1297
42. Von Ammon Cavanaugh S., Furlanetto L.M., Creech S.D., and Powell L.H. Medical illness, past depression, and present depression: a predictive triad for in-hospital mortality. Am J Psychiatry 158 (2001) 43-48
43. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15 3 (2001) 199-226